These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1424486)

  • 1. [Thrombolytic therapy in acute myocardial infarct].
    Tullio D; Valerio A
    Clin Ter; 1992 May; 140(5):447-59. PubMed ID: 1424486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of thrombolytic treatments on the mortality of myocardial infarction. Characteristics of large-scale trials, main results].
    Slama M; Cohen-Solal A; Spriet A
    Arch Mal Coeur Vaiss; 1989 Oct; 82 Spec No 3():27-33. PubMed ID: 2512885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of clinical efficacy of thrombolytic drugs in patients with acute myocardial infarction].
    López-Sendón JL
    Rev Esp Cardiol; 1992; 45 Suppl 2():9-20. PubMed ID: 1475514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myocardial infarction: treatment with thrombolytic therapy.
    Topol EJ
    Cardiol Clin; 1989 Nov; 7(4):827-36. PubMed ID: 2688884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombolytic treatment of acute myocardial infarct. 2].
    Soares-Costa TJ; Gabriel HM; Soares-Costa JT
    Acta Med Port; 1998 May; 11(5):421-9. PubMed ID: 9951052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
    Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA
    Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombolytic treatment of acute myocardial infarct. 1].
    Soares-Costa JT; Soares-Costa TJ; Gabriel HM
    Acta Med Port; 1998 May; 11(5):409-19. PubMed ID: 9951051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The characteristics of thrombolytic therapy in myocardial infarct in middle-aged and elderly patients].
    Teslia AN; Kolesnikov SA; Mikhaĭlov AA
    Voen Med Zh; 1999 Jul; 320(7):40-4. PubMed ID: 10484919
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fibrinolysis therapy using APSAC in acute myocardial infarct].
    Hochrein H
    Dtsch Med Wochenschr; 1990 Jun; 115(25):999. PubMed ID: 2193790
    [No Abstract]   [Full Text] [Related]  

  • 10. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
    Franzosi MG
    Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
    [No Abstract]   [Full Text] [Related]  

  • 11. [The optimization of the results with the use of thrombolytic therapy in acute myocardial infarct (I)].
    Cerveró Martí A
    Med Clin (Barc); 1993 May; 100(17):668-74. PubMed ID: 8497174
    [No Abstract]   [Full Text] [Related]  

  • 12. [Primary angioplasty is superior to thrombolytic therapy in also reducing long-term clinical events after acute myocardial infarct].
    Bolognese L
    Ital Heart J Suppl; 2000 Mar; 1(3):431-2. PubMed ID: 10815279
    [No Abstract]   [Full Text] [Related]  

  • 13. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25).
    Antman EM; Morrow DA; McCabe CH; Jiang F; White HD; Fox KA; Sharma D; Chew P; Braunwald E;
    Am Heart J; 2005 Feb; 149(2):217-26. PubMed ID: 15846258
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thrombolytic therapy in acute myocardial infarct].
    Aschermann M
    Cas Lek Cesk; 1990 Apr; 129(16):484-7. PubMed ID: 2340565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk-benefit of thrombolysis.
    Simoons ML
    Cardiol Clin; 1995 Aug; 13(3):339-45. PubMed ID: 7585771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.
    Evrengul H; Celek T; Tanriverdi H; Kaftan A; Dursunoglu D; Kilic M
    Can J Cardiol; 2005 Sep; 21(11):915-20. PubMed ID: 16239974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolytic therapy impact on prognosis after twelve months of first acute myocardial infarction.
    Caires G; Pereira D; Freitas AD; Teixeira F; Leite R; Araújo JJ; Cardoso A; Pereira AC; Macedo ME; Diniz M
    Rev Port Cardiol; 2000 Nov; 19(11):1103-19. PubMed ID: 11201627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient selection issues in the use of thrombolytic therapy in patients with acute myocardial infarction.
    Gore JM
    Z Kardiol; 1993; 82 Suppl 2():143-6. PubMed ID: 8328193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of thrombolytic therapy on recanalization in different starting time of treatment after acute myocardial infarction.
    Shen L; Yang J; Hu Q; Teng Y; Han X; Yan S; Lian M; Xie M; Gu F
    Chin Med J (Engl); 1997 Jan; 110(1):53-5. PubMed ID: 9594323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombolytic therapy in acute myocardial infarct--is it being used to the fullest?].
    Carôla B; Calçada-Correia L; Pedro PG; Conduto R; Dionísio I; Fiuza M; Dias E; Vaz Carneiro A; Amador MG; de Pádua F; Lopes MG
    Rev Port Cardiol; 1996 Dec; 15(12):867-76, 863. PubMed ID: 9052962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.